TAR-200 elicits high complete response rate in BCG-unresponsive NMIBC
Phase 3 trial of capivasertib in mCRPC discontinued following IDMC recommendation
Pearls & Perspectives: Evolving role of APPs in urology, with Corinna Hughes, DNP, at AUA 2025
CISTO: Radical cystectomy has key role in recurrent high-grade NMIBC